A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Clinical trial NCT07270003 · RECRUITING

Trial details

NCT number: NCT07270003
Sponsor: Xijing Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Palmoplantar Pustulosis (PPP)

Start date: 2025-10-01
Primary completion: 2026-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.